Clinical and Translational Research in Gastrointestinal Cancers

Dear Colleagues, 

Gastrointestinal (GI) cancers pose a major challenge to global public health. In 2018, Arnold and colleagues (PMID: 32247694) estimated that, there were 4.8 million new cases of GI cancers and 3.4 million related deaths, worldwide. Lu and colleagues (PMID: 34563100) have recently quantified the impact of lifestyle-related factors on causing GI cancers. There remain many options for the primary and secondary prevention of these cancers, and the management of these cancers is also evolving. Minimally invasive (laparoscopic and robotic) surgery is becoming increasingly applied to complement open surgery. Chemotherapy and radiation therapy have not only resulted in lengthening disease-free survival, but also have a significant impact on overall survival. The last decade has witnessed a paradigm shift with a growing interest in cancer survivorship and quality of life. This Special Issue aims to bring together original research, as well as impactful reviews from around the world, which highlight the progress being made in different aspects of the management, including survivorship, of a broad spectrum of GI cancers.

There is a need to highlight and celebrate impactful research being carried out across the broad spectrum of gastrointestinal (GI) cancers, bringing together original research, as well as impactful reviews from around the world highlighting the progress being made in different aspects of the management, including survivorship, of a broad spectrum of GI cancers.

Dr. Savio Barreto
Prof. Dr. Jörg Kleeff
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.